Inclusion Criteria:~1. Age ≥50 and ≤85 on the date of signing the informed consent, males or females;~2.
BMI≥18kg/m2 and ≤32 kg/m2, weight ≥45 kgä¸”≤100 kg at screening or baselineï¼›~3. must meet the diagnostic
criteria for MCI due to AD or mild AD;~4. The total score of HAMD-17 should be ≤10 scores at screening;~5. The
score of Hachinski ischemic scale should be ≤4 scores at screening;~6. amyloid PET scan results from the
central laboratory confirmed the presence of pathological changes in AD;~7. Agreed to test ApoE genotype;~8.
Have a stable caregiver; where symptomatic drugs for AD is used, they must be stable for at least 1 months
prior to the screening visit;~
